论文信息 - Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.). - 字舞流文

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).

A. Rossi | C. Gridelli | A. Russo | F. Perrone | F. Cognetti | A. Bianco | A. Bianco | C. Gallo | V. Gebbia | M. D'aprile | S. Placido | S. Palmeri | E. Veltri | G. Palazzolo | V. Leonardi | G. Airoma | P. Incoronato | A. F. Scinto | M. Natali | R. Pepe | S. De Placido | A. Russo